Advertisement - Members don't see this ad
This may not be a news for many here, but a recent JAMA publication showed that Interferone beta does not affect the eventual disability in MS patients. I am just wondering, that if this is going to change practise pattern for any one here. Would you consider introducing the stronger immunomodulators like Tysabri more readily for your patients now? Will appreciate some inputs. Thanks!
